97 related articles for article (PubMed ID: 17923244)
1. Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure.
Schots R; De Keulenaer G; Schoors D; Caveliers V; Dujardin M; Verheye S; Van Camp G; Franken PR; Roland J; Van Riet I; Everaert H
Exp Hematol; 2007 Dec; 35(12):1884-90. PubMed ID: 17923244
[TBL] [Abstract][Full Text] [Related]
2. In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease.
Caveliers V; De Keulenaer G; Everaert H; Van Riet I; Van Camp G; Verheye S; Roland J; Schoors D; Franken PR; Schots R
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):61-6. PubMed ID: 17372574
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution.
Goussetis E; Manginas A; Koutelou M; Peristeri I; Theodosaki M; Kollaros N; Leontiadis E; Theodorakos A; Paterakis G; Karatasakis G; Cokkinos DV; Graphakos S
Stem Cells; 2006 Oct; 24(10):2279-83. PubMed ID: 16794269
[TBL] [Abstract][Full Text] [Related]
4. Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency.
Flores-Ramírez R; Uribe-Longoria A; Rangel-Fuentes MM; Gutiérrez-Fajardo P; Salazar-Riojas R; Cervantes-García D; Treviño-Ortiz JH; Benavides-Chereti GJ; Espinosa-Oliveros LP; Limón-Rodríguez RH; Monreal-Puente R; González-Treviño JL; Rojas-Martínez A
Cardiovasc Revasc Med; 2010; 11(2):72-8. PubMed ID: 20347795
[TBL] [Abstract][Full Text] [Related]
5. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
[TBL] [Abstract][Full Text] [Related]
6. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.
Bartunek J; Vanderheyden M; Vandekerckhove B; Mansour S; De Bruyne B; De Bondt P; Van Haute I; Lootens N; Heyndrickx G; Wijns W
Circulation; 2005 Aug; 112(9 Suppl):I178-83. PubMed ID: 16159812
[TBL] [Abstract][Full Text] [Related]
7. Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial.
Forcillo J; Stevens LM; Mansour S; Prieto I; Salem R; Baron C; Roy DC; Larose E; Masckauchan D; Noiseux N
Can J Cardiol; 2013 Apr; 29(4):441-7. PubMed ID: 23265095
[TBL] [Abstract][Full Text] [Related]
8. Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial.
Andreone P; Catani L; Margini C; Brodosi L; Lorenzini S; Sollazzo D; Nicolini B; Giordano R; Montemurro T; Rizzi S; Dan E; Giudice V; Viganò M; Casadei A; Foschi FG; Malvi D; Bernardi M; Conti F; Lemoli RM
Dig Liver Dis; 2015 Dec; 47(12):1059-66. PubMed ID: 26427587
[TBL] [Abstract][Full Text] [Related]
9. Stem cell therapy for the broken heart: mini-organ transplantation.
Mansour S; Roy DC; Lemieux B; Ouellet C; Stevens LM; Noiseux N
Transplant Proc; 2009 Oct; 41(8):3353-7. PubMed ID: 19857748
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.
Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE
Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780
[TBL] [Abstract][Full Text] [Related]
11. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium.
Schächinger V; Aicher A; Döbert N; Röver R; Diener J; Fichtlscherer S; Assmus B; Seeger FH; Menzel C; Brenner W; Dimmeler S; Zeiher AM
Circulation; 2008 Sep; 118(14):1425-32. PubMed ID: 18794392
[TBL] [Abstract][Full Text] [Related]
12. Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells.
Ma N; Ladilov Y; Moebius JM; Ong L; Piechaczek C; Dávid A; Kaminski A; Choi YH; Li W; Egger D; Stamm C; Steinhoff G
Cardiovasc Res; 2006 Jul; 71(1):158-69. PubMed ID: 16730684
[TBL] [Abstract][Full Text] [Related]
13. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.
Klein HM; Ghodsizad A; Marktanner R; Poll L; Voelkel T; Mohammad Hasani MR; Piechaczek C; Feifel N; Stockschlaeder M; Burchardt ER; Kar BJ; Gregoric I; Gams E
Heart Surg Forum; 2007; 10(1):E66-9. PubMed ID: 17162408
[TBL] [Abstract][Full Text] [Related]
14. Myocardial homing and coronary endothelial function after autologous blood CD34+ progenitor cells intracoronary injection in the chronic phase of myocardial infarction.
Dedobbeleer C; Blocklet D; Toungouz M; Lambermont M; Unger P; Degaute JP; Goldman S; Berkenboom G
J Cardiovasc Pharmacol; 2009 Jun; 53(6):480-5. PubMed ID: 19433985
[TBL] [Abstract][Full Text] [Related]
15. Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction.
Kang WJ; Kang HJ; Kim HS; Chung JK; Lee MC; Lee DS
J Nucl Med; 2006 Aug; 47(8):1295-301. PubMed ID: 16883008
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease.
Powell TM; Paul JD; Hill JM; Thompson M; Benjamin M; Rodrigo M; McCoy JP; Read EJ; Khuu HM; Leitman SF; Finkel T; Cannon RO
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):296-301. PubMed ID: 15569821
[TBL] [Abstract][Full Text] [Related]
17. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
Stamm C; Kleine HD; Choi YH; Dunkelmann S; Lauffs JA; Lorenzen B; David A; Liebold A; Nienaber C; Zurakowski D; Freund M; Steinhoff G
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):717-25. PubMed ID: 17320570
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus impairs CD133+ progenitor cell function after myocardial infarction.
Vöö S; Dunaeva M; Eggermann J; Stadler N; Waltenberger J
J Intern Med; 2009 Feb; 265(2):238-49. PubMed ID: 19019194
[TBL] [Abstract][Full Text] [Related]
19. The recombinant bifunctional protein αCD133-GPVI promotes repair of the infarcted myocardium in mice.
Baumer Y; Leder C; Ziegler M; Schönberger T; Ochmann C; Perk A; Degen H; Schmid-Horch B; Elvers M; Münch G; Ungerer M; Schlosshauer B; Gawaz M
J Thromb Haemost; 2012 Jun; 10(6):1152-64. PubMed ID: 22448969
[TBL] [Abstract][Full Text] [Related]
20. Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure.
Bonaros N; Rauf R; Werner E; Schlechta B; Rohde E; Kocher A; Bonatti J; Laufer G
Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):249-55. PubMed ID: 17925321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
